$Clinical Characteristics of Elderly Patients with Refractory Gastroesophageal Reflux Disease$

Clinical Characteristics of Elderly Patients with Refractory Gastroesophageal Reflux Disease

Background: Gastroesophageal reflux disease (GERD) is a common upper gastrointestinal disease, and almost 30% of GERD patients do not respond well to proton pump inhibitor (PPI) therapy. The aim of this study is to evaluate the clinical characteristics of elderly GERD patients who either respond to...

Full description

Bibliographic Details
Main Authors:	Ying-Nan Li, Xiao-Ning Zhao, Ting-Ting Li, Chang-Zheng Wang, Wei-Hua Wang, Lei Tian, Ben-Yan Wu
Format:	Article
Language:	English
Published:	Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM) 2016-06-01
Series:	International Journal of Gerontology
Subjects:	gastroesophageal reflux disease geriatrics human characteristics proton pump inhibitors
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873959816300400

Similar Items

Gastroesophageal Reflux Disease: diagnosis and treatment
by: Michał Zdybel, et al.
Published: (2023-05-01)

Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease
by: V T Ivashkin, et al.
Published: (2018-08-01)

Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?
by: Deepanshu Jain, et al.
Published: (2016-03-01)

Gastroesophageal reflux disease: exaggerations, evidence and clinical practice
by: Cristina Targa Ferreira, et al.
Published: (2014-03-01)

Refractory Gastroesophageal Reflux Disease: Pathophysiology, Diagnosis, and Management
by: Zaheer Nabi, et al.
Published: (2019-12-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
by: Sirinawasatien A, et al.
Published: (2019-07-01)

Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01)

Current advances in the diagnosis and management of gastroesophageal reflux disease
by: Shu-Wei Liang, et al.
Published: (2022-01-01)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01)

Practical Aspects of Pathogenetic Therapy for Gastroesophageal Reflux Disease
by: V.P. Shipulin
Published: (2015-02-01)

Anti-Reflux Mucosal Ablation: One More Kid in Town for the Treatment of Gastroesophageal Reflux Disease
by: Isabel Garrido, et al.
Published: (2023-12-01)

Proton pumps inhibitors in gastroesophageal reflux disease: what is the best regimen? A based evidence review
by: Rui JF Silva, et al.
Published: (2021-07-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

Complex Gastroesophageal Reflux Disease
by: Diana L. Snyder, et al.
Published: (2022-01-01)

Gastroesophageal reflux and PPI exposure alter gut microbiota in very young infants
by: Denease Francis, et al.
Published: (2023-10-01)

DIAGNOSIS AND TREATMENT IN GASTROESOPHAGEAL REFLUX DISEASE – POSSIBILITIES AND LIMITATIONS
by: Gabriela Ciubotariu, et al.
Published: (2016-09-01)

ACTUAL ASPECTS OF ANTI-SECRETOR THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE
by: D. I. Trukhan, et al.
Published: (2017-11-01)

Peculiarities of Treating Bronchial Asthma Associated with Gastroesophageal Reflux Disease
by: I.O. Borovyk, et al.
Published: (2014-02-01)

Diagnosis and Treatment of Refractory Gastroesophageal Reflux Disease (GERD)
by: Selfie, et al.
Published: (2015-12-01)

Gastroesophageal reflux disease: new approaches to optimizing pharmacotherapy
by: D. N. Andreev, et al.
Published: (2021-05-01)

Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01)

Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2024-03-01)

EMPIRIC THERAPY IN OTOLARYNGOLOGIC MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE
by: M. Mohammadi, et al.
Published: (2005-02-01)

EMPIRIC THERAPY IN OTOLARYNGOLOGIC MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE
by: M. Mohammadi, et al.
Published: (2005-04-01)

Refractory gastroesophageal reflux disease Doença do refluxo gastroesofágico refratária
by: Joaquim Prado P. Moraes-Filho
Published: (2012-12-01)

Diagnosis and treatment of gastroesophageal reflux disease
by: Aleksandr Sergeevich Trukhmanov, et al.
Published: (2011-08-01)

How useful is antireflux surgery in lung transplant patients with gastroesophageal reflux?
by: Victoria Pegna, et al.
Published: (2014-01-01)

The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study
by: Hong Jun Park, et al.
Published: (2016-07-01)

The Impact of Direct-to-Consumer Pharmaceutical Advertising on Public Knowledge of Gastroesophageal Reflux Disease: A Study on Over-the-Counter Proton Pump Inhibitors
by: AlShammari M, et al.
Published: (2020-03-01)

Efficacy of Endoscopic and Surgical Treatments for Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-Analysis
by: Eun Jeong Gong, et al.
Published: (2022-04-01)

Proton pump inhibitors as treatment of laryngeal disorders among patients with gastroesophageal reflux disease: a single-arm (pre and post) quasi-experimental study
by: Mahmoud Ali Ragaee, et al.
Published: (2023-01-01)

GASTROESOPHAGEAL REFLUX: NEW THERAPEUTIC PROSPECTS
by: S. S. Kardasheva, et al.
Published: (2017-07-01)

COMPARISON OF THE EFFICACIES OF PROTON PUMP INHIBITORS AND H2 RECEPTOR ANTAGONISTS IN ON-DEMAND TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
by: Nesibe Vardı, et al.
Published: (2018-08-01)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01)

Possibilities of pH impedance and high-resolution manometry in managing patients with refractory gastroesophageal reflux disease
by: I V Maev, et al.
Published: (2017-02-01)

Gastroesophageal reflux and idiopathic pulmonary fibrosis: A long term relationship
by: Karthik Gnanapandithan, et al.
Published: (2016-01-01)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
by: Mousalreza Hosseini, et al.
Published: (2017-06-01)

Results of the study of conservative treatment of laryngeal manifestations of laryngopharyngeal reflux
by: I. B. Angotoeva, et al.
Published: (2021-12-01)

The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)